CSL

Company Overview

CSL is an international company that specializes in manufacturing biotherapeutic products. The company manufactures and supplies innovative biotherapeutic products that offer safe treatments to people suffering from chronic medical conditions. The company has a major geographical presence in Australia, Germany, Switzerland, the U.K. and the U.S. The company employs approximately 32,000 people, who operate in over 40 countries. The company has achieved expertise in R&D, plasma products, vaccines and pharmaceuticals. As a global leader in influenza protection, Seqirus has one of the broadest influenza vaccine portfolios in the world. In the Asia-Pacific region, the company provides a wide range of vaccines and specialty medicines that meet unique, local public health needs.

CSL Behring is part the CoVIg-19 Plasma Alliance, an industry partnership formed to develop a potential plasma-derived therapy for treating COVID-19. The CoVIg-19 Plasma Alliance is developing an investigational anti-coronavirus hyperimmune intravenous immunoglobulin medicine for treating hospitalized adults at risk for serious complications of COVID-19 disease.

Financial Highlights (FY 2023)

Company's Business Segments

• CSL Behring : Immunology, Hematology, Respiratory, Albumin
• CSL Seqirus : Egg based vaccines, Cell culture vaccines, Adjuvanted egg based vaccines, Pandemic, Other (including in-license)
• CSL Vifor : Iron deficiency and Iron deficiency anemia, Nephrology